Home > Boards > Free Zone > Big Board Trading - Technical > *SCALPSWINGSTRADDLE* ($$$)

Pharmacyclics pullback a buying opportunity, says Credit Suisse

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
madrose1 Member Profile
Member Level 
Followed By 301
Posts 47,229
Boards Moderated 10
Alias Born 04/07/01
160x600 placeholder
U.S. Stocks: Futures Lower; Amazon Tumbles
U.S. stock futures leaned lower Friday, as Amazon.com Inc. tumbled in premarket trade after disappointing results and Xerox Corp. and Starbucks Corp. also fell post-earnings.
Top Equities Stories Of The Day
Shire Files 8K - Entry Into Definitive Agreement
U.K. Equities Take the Limelight in European Markets
FDA OK's Flonase for Sale Over the Counter in U.S.
Have Big-Screen Smartphones Crashed the Tablet Party?
U.S. Stocks Inch Higher on Jobless Report, Earnings
European Stocks Slip; Shire Leads FTSE Gains
BofA to Pay $16.6 Million to Settle Alleged Sanctions Violations
H-P, Hortonworks Extend Partnership on Big Data
madrose1 Member Level  Monday, 03/25/13 08:37:55 AM
Re: None
Post # of 641320 
Pharmacyclics pullback a buying opportunity, says Credit Suisse
Credit Suisse would use the pullback in Pharmacyclics as a buying opportunity given the multi-billion dollar potential of ibrutinib. Shares are Outperform rated with a $90 price target

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist